Both medications work by mimicking the GLP-1 hormone, which regulates appetite and food intake
Many patients notice meaningful improvements in portion control, cravings, and consistency over time
Youll complete a virtual medical evaluation, and if approved, your prescription is delivered to your home
Reduced caloric intake from appetite suppression can contribute to fatigue, as can the metabolic adjustments your body makes in response to GLP-1 receptor activation
Email us at [email protected], wed love to talk to you
In June 2021, the FDA approved Wegovy for chronic weight management for adults with obesity (BMI 30kg/m2) or overweight (BMI 27kg/m2) and related comorbidities with at least one weight-related comorbidity, to be administered subcutaneously at 2.4mg once weekly